Myostatin: more than just a regulator of muscle mass
Abstract
The presence of sufficient skeletal muscle mass is of paramount importance for body function and the myostatin cascade is known to inhibit muscle growth in mammals. In addition, myostatin seems to have an important role in the cross-talk between skeletal muscle and adipose tissue and is involved in insulin sensitivity. In this article we highlight the latest developments related to the myostatin system, emphasizing therapeutic implications for wasting diseases and also the involvement of the system in other organs, in addition to skeletal muscle, such as heart or adipose tissue. Moreover, we highlight the possible role of the myostatin system in the cross-talk between skeletal muscle and adipose tissue, an important aspect that deserves consideration in wasting diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Myostatin is also expressed and secreted in adulthood.
“However, it is known today that myostatin is also expressed and secreted even in adulthood (Argiles et al., 2012).”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Argiles et al., 2012
Myostatin promotes muscle atrophy, in part by inhibiting AKT and mTOR signaling.
“Myostatin was first described to be secreted during development to limit muscle growth 143, but is also known today to be produced in adults 144, and to promote muscle atrophy, in part by inhibiting AKT and mTOR signaling.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [144]
Myostatin is produced in adults.
“Myostatin was first described to be secreted during development to limit muscle growth 143, but is also known today to be produced in adults 144, and to promote muscle atrophy, in part by inhibiting AKT and mTOR signaling.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [144]
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,800 · see citing works
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013 · see citing works
Evans, W., Morley, J., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,341 · see citing works
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014 · see citing works
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T. C., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 941 · see citing works
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B. C., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 910 · see citing works
Induction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P. A., Esquela‐Kerscher, A., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S. (2002) · Science · doi:10.1126/science.1069525 · Cited by 908 · see citing works
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831 · see citing works
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819 · see citing works
Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia
Das, S. K., Eder, S., Schauer, S., Diwoky, C., Temmel, H., Guertl, B., Gorkiewicz, G., Tamilarasan, K. P., Kumari, P., Trauner, M. A., et al. (2011) · Science · doi:10.1126/science.1198973 · Cited by 586 · see citing works
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571 · see citing works
Suppression of body fat accumulation in myostatin-deficient mice
McPherron, A. C., & Lee, S.-J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213562 · Cited by 505 · see citing works
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength
Whittemore, L.-A., Song, K., Li, X., Aghajanian, J. D., Davies, M. V., Girgenrath, S., Hill, J. J., Jalenak, M., Kelley, P. E., Knight, A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02953-4 · Cited by 503 · see citing works
McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M. G., Ling, N., Smith, H., Sharma, M., & Kambadur, R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20757 · Cited by 480 · see citing works
The transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464 · see citing works
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases
Wolfman, N. M., McPherron, A. C., Pappano, W. N., Davies, M. V., Song, K., Tomkinson, K. N., Wright, J. F., Zhao, L., Sebald, S. M., Greenspan, D. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2534946100 · Cited by 454 · see citing works
Hill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206379200 · Cited by 444 · see citing works
Lack of myostatin results in excessive muscle growth but impaired force generation
Amthor, H., Macharia, R., Navarrete, R., Schuelke, M., Brown, S., Otto, A., Voït, T., Francesco Muntoni, A., Vrbovà, G., Partridge, T. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604893104 · Cited by 425 · see citing works
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & González-Cadavid, N. F. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410 · see citing works
Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., & McPherron, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004937 · Cited by 402 · see citing works
Signaling pathways perturbing muscle mass.
Glass, D. J. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833862df · Cited by 359 · see citing works
Minetti, G., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V., Fortuni, S., Straino, S., Sampaolesi, M., Padova, M. D., et al. (2006) · Nature Medicine · doi:10.1038/nm1479 · Cited by 341 · see citing works
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324 · see citing works
Yarasheski, K. E., Bhasin, S., Sinha‐Hikim, I., Pak-Loduca, J., & González-Cadavid, N. F. (2002) · PubMed · Cited by 293 · see citing works
Léger, B., Derave, W., Bock, K. D., Hespel, P., & Russell, A. P. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0588 · Cited by 274 · see citing works
Myostatin and the control of skeletal muscle mass
Lee, S., & McPherron, A. C. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00004-0 · Cited by 273 · see citing works
Myostatin decreases with aerobic exercise and associates with insulin resistance
HITTEL, D. S., AXELSON, M., SARNA, N., SHEARER, J., HUFFMAN, K. M., & KRAUS, W. E. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0b9a8 · Cited by 271 · see citing works
Structure of the ternary signaling complex of a TGF-β superfamily member
Allendorph, G. P., Vale, W., & Choe, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602558103 · Cited by 247 · see citing works
Iezzi, S., Padova, M. D., Serra, C., Caretti, G., Simone, C., Maklan, E., Minetti, G., Zhao, P., Hoffman, E. P., Puri, P., et al. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00107-8 · Cited by 238 · see citing works
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
Heineke, J., Auger-Messier, M., Xu, J., Sargent, M., York, A., Welle, S., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.109.882068 · Cited by 238 · see citing works
Klimek, M. B., Aydogdu, T., Link, M., Pons, M., Koniaris, L. G., & Zimmers, T. A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.123 · Cited by 229 · see citing works
Trayhurn, P., Drevon, C. A., & Eckel, J. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2010.535835 · Cited by 214 · see citing works
The role of cytokines in cancer cachexia
Argilés, J. M. A., Busquets, S., Toledo, M., & López-Soriano, F. J. (2009) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3283311d09 · Cited by 211 · see citing works
Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects
Feldman, B. J., Streeper, R. S., Farese, R. V., & Yamamoto, K. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607501103 · Cited by 210 · see citing works
Artaza, J. N., Bhasin, S., Magee, T. R., Reisz‐Porszasz, S., Shen, R., Groome, N. P., Fareez, M. M., & González-Cadavid, N. F. (2005) · Endocrinology · doi:10.1210/en.2005-0362 · Cited by 207 · see citing works
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure.
Elkasrawy, M., & Hamrick, M. W. (2010) · PubMed · Cited by 203 · see citing works
Hansen, J., Brandt, C., Nielsen, A. R., Hojman, P., Whitham, M., Febbraio, M. A., Pedersen, B. K., & Plomgaard, P. (2011) · Endocrinology · doi:10.1210/en.2010-0868 · Cited by 200 · see citing works
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194 · see citing works
Cross-talk between skeletal muscle and adipose tissue: A link with obesity?
Argilés, J. M. A., López‐Soriano, J., Almendro, V., Busquets, S., & López-Soriano, F. J. (2004) · Medicinal Research Reviews · doi:10.1002/med.20010 · Cited by 194 · see citing works
Zhang, C., McFarlane, C., Lokireddy, S., Masuda, S., Ge, X., Gluckman, P. D., Sharma, M., & Kambadur, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2304-4 · Cited by 192 · see citing works
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
Zhao, B., Wall, R. J., & Yang, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.044 · Cited by 186 · see citing works
Llovera, M., Garcia‐Martínez, C., Agell, N., López-Soriano, F. J., & Argilés, J. M. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5827 · Cited by 184 · see citing works
Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., & Mehan, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00798.2007 · Cited by 183 · see citing works
Muscle myostatin signalling is enhanced in experimental cancer cachexia
Costelli, P., Muscaritoli, M., Bonetto, A., Penna, F., Reffo, P., Bossola, M., Bonelli, G., Doglietto, G. B., Baccino, F. M., & Fanelli, F. R. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01970.x · Cited by 181 · see citing works
Anticachectic Effects of Formoterol
Busquets, S., Figueras, M. T., Fuster, G., Almendro, V., Moore‐Carrasco, R., Ametller, E., Argilés, J. M. A., & López-Soriano, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0425 · Cited by 167 · see citing works
Increased muscle ubiquitin mRNA levels in gastric cancer patients.
Bossola, M., Muscaritoli, M., Costelli, P., Bellantone, R., Pacelli, F., Busquets, S., Argilès, J., López-Soriano, F., Civello, I. M., Baccino, F., et al. (2001) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1518 · Cited by 164 · see citing works
Durieux, A., Amirouche, A., Banzet, S., Koulmann, N., Bonnefoy, R., Pasdeloup, M., Mouret, C., Bigard, X. A., Peinnequin, A., & Freyssenet, D. G. (2007) · Endocrinology · doi:10.1210/en.2006-1500 · Cited by 162 · see citing works
The myostatin gene: physiology and pharmacological relevance
Joulia-Ekaza, D., & Cabello, G. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.011 · Cited by 160 · see citing works
Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M., & Kambadur, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2079-7 · Cited by 158 · see citing works
Qiao, C., Li, J., Jiang, J., Zhu, X., Wang, B., Li, J., & Xiao, X. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.159 · Cited by 157 · see citing works
Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle
Anderson, S. B., Goldberg, A. L., & Whitman, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706678200 · Cited by 150 · see citing works
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
Akpan, I., Goncalves, M. D., Dhir, R., Yin, X., Pistilli, E. E., Bogdanovich, S., Khurana, T. S., Ucran, J., Lachey, J., & Ahima, R. S. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.162 · Cited by 140 · see citing works
Lenk, K., Erbs, S., Höllriegel, R., Beck, E. B., Linke, A. H.-P., Gielen, S., Winkler, S. M., Sandri, M., Hambrecht, R., Schuler, G. C., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711402735 · Cited by 140 · see citing works
Prolonged absence of myostatin reduces sarcopenia
Siriett, V., Platt, L., Salerno, M. S., Ling, N., Kambadur, R., & Sharma, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20778 · Cited by 139 · see citing works
Amthor, H., Huang, R., McKinnell, I. W., Christ, B., Kambadur, R., Sharma, M., & Patel, K. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0812 · Cited by 138 · see citing works
Lenk, K., Schur, R., Linke, A., Erbs, S., Matsumoto, Y., Adams, V., & Schuler, G. C. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp020 · Cited by 136 · see citing works
Ryan, A. S., Ivey, F. M., Prior, S. J., Li, G., & Hafer‐Macko, C. E. (2010) · Stroke · doi:10.1161/strokeaha.110.602441 · Cited by 131 · see citing works
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
Breitbart, A., Auger‐Messier, M., Molkentin, J. D., & Heineke, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2011 · Cited by 131 · see citing works
Kishioka, Y., Thomas, M., Wakamatsu, J., Hattori, A., Sharma, M., Kambadur, R., & Nishimura, T. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21371 · Cited by 130 · see citing works
Steelman, C. A., Recknor, J. C., Nettleton, D. S., & Reecy, J. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-5125fje · Cited by 129 · see citing works
Recent advances in the biology and therapy of muscle wasting
Glass, D. J., & Roubenoff, R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05809.x · Cited by 127 · see citing works
Murphy, K. T., Koopman, R., Naim, T., Léger, B., Trieu, J., Ibebunjo, C., & Lynch, G. S. (2010) · The FASEB Journal · doi:10.1096/fj.10-159608 · Cited by 124 · see citing works
Muscular atrophy of caveolin-3–deficient mice is rescued by myostatin inhibition
Ohsawa, Y., Hagiwara, H., Nakatani, M., Yasue, A., Moriyama, K., Murakami, T., Tsuchida, K., Noji, S., & Sunada, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28520 · Cited by 120 · see citing works
Genetic Analysis of the Role of Proteolysis in the Activation of Latent Myostatin
Lee, S.-J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001628 · Cited by 113 · see citing works
Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells
Huang, Z., Chen, D., Zhang, K., Yu, B., Chen, X., & Meng, J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.002 · Cited by 104 · see citing works
Structure to function: muscle failure in critically ill patients
Puthucheary, Z., Montgomery, H., Moxham, J., Harridge, S. D. R., & Hart, N. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.197632 · Cited by 103 · see citing works
Changes in Muscle Myostatin Expression in Obese Subjects after Weight Loss
Milan, G., Nora, E. D., Pilon, C., Pagano, C., Granzotto, M., Manco, M., Mingrone, G., & Vettor, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032047 · Cited by 100 · see citing works
Myostatin Up-Regulation Is Associated with the Skeletal Muscle Response to Hypoxic Stimuli
Hayot, M., Rodriguez, J., Vernus, B., Carnac, G., Jean, E., Allen, D., Goret, L., Obert, P., Candau, R., & Bonnieu, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.008 · Cited by 98 · see citing works
Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice
Cm, L., Yang, Z., Liu, C.-W., Wang, R., Tien, P., Dale, R., & Sun, L.-Q. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303016 · Cited by 98 · see citing works
Dejong, C. H. C., Busquets, S., Moses, A. G. W., Schrauwen, P., Ross, J. A., Argilés, J. M. A., & Fearon, K. C. H. (2005) · Oncology Reports · doi:10.3892/or.14.1.257 · Cited by 90 · see citing works
Atrophy and hypertrophy signalling in the diaphragm of patients with COPD
Testelmans, D., Crul, T., Maes, K., Agten, A., Crombach, M., Decramer, M., & Gayan‐Ramirez, G. (2009) · European Respiratory Journal · doi:10.1183/09031936.00091108 · Cited by 87 · see citing works
Targeting myostatin for therapies against muscle-wasting disorders.
Tsuchida, K. (2008) · PubMed · Cited by 84 · see citing works
Myostatin in Muscle Growth and Repair
Sharma, M., Langley, B. C., Bass, J. J., & Kambadur, R. (2001) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200110000-00004 · Cited by 84 · see citing works
Changes in Myostatin Signaling in Non-Weight-Losing Cancer Patients
Aversa, Z., Bonetto, A., Penna, F., Costelli, P., Rienzo, G. D., Lacitignola, A., Baccino, F. M., Ziparo, V., Mercantini, P., Fanelli, F. R., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1720-5 · Cited by 83 · see citing works
Dumonceaux, J., Marie, S., Beley, C., Trollet, C., Vignaud, A., Ferry, A., Butler-Browne, G. S., & Garcı́a, L. (2010) · Molecular Therapy · doi:10.1038/mt.2009.322 · Cited by 79 · see citing works
Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice
Cm, L., Yang, Z., Liu, C.-W., Wang, R., Tien, P., Dale, R., & Sun, L.-Q. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701091 · Cited by 78 · see citing works
Bogdanovich, S., McNally, E. M., & Khurana, T. S. (2007) · Muscle & Nerve · doi:10.1002/mus.20920 · Cited by 74 · see citing works
Salehian, B., Mahabadi, V., Bilas, J., Taylor, W. E., & Ma, K. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.009 · Cited by 69 · see citing works
Bonetto, A., Penna, F., Minero, V. G., Reffo, P., Bonelli, G., Baccino, F. M., & Costelli, P. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789057015 · Cited by 69 · see citing works
Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice
Morine, K., Bish, L. T., Pendrak, K., Sleeper, M. M., Barton, E. R., & Sweeney, H. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009176 · Cited by 64 · see citing works
Chen, Y., Cao, L., Ye, J., & Zhu, D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.129 · Cited by 63 · see citing works
Role of Follistatin in Promoting Adipogenesis in Women
Flanagan, J. N., Linder, K., Mejhert, N., Dungner, E., Wåhlén, K., Decaunes, P., Rydén, M., Björklund, P., Arver, S., Bhasin, S., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2005 · Cited by 63 · see citing works
Sprinting without myostatin: a genetic determinant of athletic prowess
Lee, S. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.08.008 · Cited by 61 · see citing works
Mechanisms to explain wasting of muscle and fat in cancer cachexia
Argilés, J. M. A., López-Soriano, F. J., & Busquets, S. (2007) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3282f34738 · Cited by 57 · see citing works
Benabdallah, B., Bouchentouf, M., Rousseau, J., Bigey, P., Michaud, A., Chapdelaine, P., Scherman, D., & Tremblay, J. P. (2008) · Cell Transplantation · doi:10.3727/096368908784153913 · Cited by 51 · see citing works
Quadriceps Myostatin Expression in COPD
D-C. Man, W., Natanek, S. A., Riddoch-Contreras, J., Lewis, A., Marsh, G. S., Kemp, P. R., & Polkey, M. I. (2010) · European Respiratory Journal · doi:10.1183/09031936.00032510 · Cited by 48 · see citing works
Myostatin regulates preadipocyte differentiation and lipid metabolism of adipocyte via ERK1/2
Li, F., Yang, H., Duan, Y., & Yin, Y. (2011) · Cell Biology International · doi:10.1042/cbi20110112 · Cited by 47 · see citing works
Bonetto, A., Penna, F., Minero, V. G., Reffo, P., Costamagna, D., Bonelli, G., Baccino, F. M., & Costelli, P. (2010) · Amino Acids · doi:10.1007/s00726-010-0683-3 · Cited by 43 · see citing works
Fakhfakh, R., Michaud, A., & Tremblay, J. P. (2010) · Molecular Therapy · doi:10.1038/mt.2010.171 · Cited by 42 · see citing works
Suzuki, S., Zhao, B., & Yang, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.092 · Cited by 36 · see citing works
Nakatani, M., Kokubo, M., Ohsawa, Y., Sunada, Y., & Tsuchida, K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2010 · Cited by 34 · see citing works
Interaction between myostatin and extracellular matrix components
Miura, T., Kishioka, Y., Wakamatsu, J., Hattori, A., & Nishimura, T. (2009) · Animal Science Journal · doi:10.1111/j.1740-0929.2009.00700.x · Cited by 33 · see citing works
Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter
Bartholin, L., Guindon, S., Martel, S., Corbo, L., & Rimokh, R. (2007) · Gene · doi:10.1016/j.gene.2007.02.007 · Cited by 24 · see citing works
Towards a fluorescent chemoreceptive lipid membrane-based optode
Krull, U. J. (1988) · Talanta · doi:10.1016/0039-9140(88)80051-1 · Cited by 19 · see citing works
Post-exercise changes in myostatin and actRIIB expression in obese insulin-resistant rats
Bueno, P. G., Bassi, D., Contrera, D. G., Carnielli, H. M., Silva, R. N., Nonaka, K. O., Selistre-de-Araújo, H. S., & Leal, A. M. O. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.006 · Cited by 13 · see citing works
Flagged first, then by citations
3 of the 98 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cancer cachexia: understanding the molecular basis
Argilés, J. M. A., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3829 · Cited by 1,518 · see citing works
Leal, L. G., Lopes, M. A., & Batista, M. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01307 · Cited by 382 · see citing works
“However, it is known today that myostatin is also expressed and secreted even in adulthood (Argiles et al., 2012).”
BackgroundCancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
da Silva, S. P., Santos, J., Silva, M. P. C. E., da Costa, R. M. G., & Medeiros, R. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12528 · Cited by 375 · see citing works
Inter-tissue communication in cancer cachexia
Argilés, J. M. A., Stemmler, B., López-Soriano, F. J., & Busquets, S. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0123-0 · Cited by 305 · see citing works
Shan, T., Liang, X., Bi, P., & Kuang, S. (2013) · The FASEB Journal · doi:10.1096/fj.12-225755 · Cited by 301 · see citing works
Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update
Jiménez-Gutiérrez, G. E., Martínez-Gómez, L. E., Martínez-Armenta, C., Pineda, C., Martínez‐Nava, G. A., & López-Reyes, A. G. (2022) · Cells · doi:10.3390/cells11152359 · Cited by 243 · see citing works
Inter‐organ communication: a gatekeeper for metabolic health
Castillo‐Armengol, J., Fajas, L., & Lopez‐Mejia, I. C. (2019) · The EMBO Reports · doi:10.15252/embr.201947903 · Cited by 178 · see citing works
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151 · see citing works
Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
Smith, R. C., & Lin, B. K. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000013 · Cited by 151 · see citing works
Sarcopenic obesity: how do we treat it?
Bouchonville, M. F., & Villareal, D. T. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000433071.11466.7f · Cited by 141 · see citing works
Myokines and Resistance Training: A Narrative Review
Zunner, B. E. M., Wachsmuth, N. B., Eckstein, M. L., Scherl, L., Schierbauer, J., Haupt, S., Stumpf, C., Reusch, L., & Moser, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073501 · Cited by 139 · see citing works
Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients
Júnior, M. L. B., Henriques, F. D. S., das Neves, R. X., Oliván, M., de Matos‐Neto, E. M., de Alcântara, P. S. M., Maximiano, L. F., Otoch, J. P., Alves, M. J., & Seelaender, M. C. L. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12037 · Cited by 117 · see citing works
Mueller, T. C., Bachmann, J., Prokopchuk, O., Friess, H., & Martignoni, M. E. (2016) · BMC Cancer · doi:10.1186/s12885-016-2121-8 · Cited by 95 · see citing works
Effect of bimagrumab on thigh muscle volume and composition in men with casting‐induced atrophy
Rooks, D. S., Laurent, D., Praestgaard, J., Rasmussen, S., Bartlett, M., & Tankó, L. B. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12205 · Cited by 90 · see citing works
Marceca, G. P., Londhe, P., & Calore, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00298 · Cited by 90 · see citing works
Cole, C. L., Kleckner, I. R., Jatoi, A., Schwarz, E. M., & Dunne, R. F. (2018) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v3i2.65 · Cited by 84 · see citing works
Myostatin – The Holy Grail for Muscle, Bone, and Fat?
Buehring, B., & Binkley, N. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0160-5 · Cited by 79 · see citing works
Harper (2016) · doi:10.1161/circresaha.116.307962 · Cited by 74 · see citing works
Mediators of cachexia in cancer patients
Argilés, J. M. A., López-Soriano, F. J., & Busquets, S. (2019) · Nutrition · doi:10.1016/j.nut.2019.03.012 · Cited by 75 · see citing works
Martín, A., Priego, T., & López-Calderón, A. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-1435-3_9 · Cited by 68 · see citing works
Miroshnychenko, O., Chang, W., & Dragoo, J. L. (2016) · The American Journal of Sports Medicine · doi:10.1177/0363546516677547 · Cited by 70 · see citing works
Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management
Siff, T., Parajuli, P., Razzaque, M., & Atfi, A. (2021) · Trends in endocrinology and metabolism · doi:10.1016/j.tem.2021.03.007 · Cited by 62 · see citing works
Advances in research on pharmacotherapy of sarcopenia
Feike, Y., Liu, Z., & Chen, W. (2021) · Aging Medicine · doi:10.1002/agm2.12168 · Cited by 67 · see citing works
Vamvini, M. T., Aronis, K. N., Panagiotou, G., Huh, J. Y., Chamberland, J. P., Brinkoetter, M. T., Petrou, M., Christophi, C. A., Kales, S. N., Christiani, D. C., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0276 · Cited by 63 · see citing works
Tao, J. J., Cangemi, N. A., Makker, V., Cadoo, K. A., Liu, J. F., Rasco, D. W., Navarro, W. H., Haqq, C. M., & Hyman, D. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1065 · Cited by 60 · see citing works
Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy
Saitoh, M., Ishida, J., Ebner, N., Anker, S. D., Springer, J., & von Haehling, S. (2017) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v2i1.37 · Cited by 57 · see citing works
Pharmacological prospects in the treatment of Duchenne muscular dystrophy
Rüegg, U. T. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328364fbaf · Cited by 56 · see citing works
Duchenne muscular dystrophy: an updated review of common available therapies
Salmaninejad, A., Valilou, S. F., Bayat, H., Ebadi, N., Daraei, A., Yousefi, M., Nesaei, A., & Mojarrad, M. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1430694 · Cited by 56 · see citing works
Myostatin — From the Mighty Mouse to cardiovascular disease and cachexia
Dschietzig, T. B. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.021 · Cited by 55 · see citing works
Qi, H., Ren, J., Ba, L., Song, C., Zhang, Q., Cao, Y., Shi, P., Fu, B., Liu, Y., & Sun, H. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.003 · Cited by 54 · see citing works
Low-intensity pulsed ultrasound prevents muscle atrophy induced by type 1 diabetes in rats
Tang, L., Li, N., Jian, W., Kang, Y., Yin, B., Sun, S., Guo, J., Sun, L., & Ta, D. (2017) · Skeletal Muscle · doi:10.1186/s13395-017-0145-7 · Cited by 50 · see citing works
Freire, P. P., Fernández, G. J., Cury, S. S., de Moraes, D., Oliveira, J. S., de Oliveira, G., Dal‐Pai‐Silva, M., Reis, P. P., & Carvalho, R. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081962 · Cited by 47 · see citing works
Growth differentiation factor 8 down-regulates pentraxin 3 in human granulosa cells
Chang, H., Fang, L., Cheng, J., Klausen, C., Sun, Y., & Leung, P. C. K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.036 · Cited by 45 · see citing works
Muscle wasting in osteoarthritis model induced by anterior cruciate ligament transection
Silva, J. M. D. S., Alabarse, P. V. G., Teixeira, V. D. O. N., Freitas, E. C., de Oliveira, F. H., Chakr, R. M. D. S., & Xavier, R. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196682 · Cited by 45 · see citing works
Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis
Little, R. D., Prieto‐Potín, I., Pérez-Baos, S., Villalvilla, A., Gratal, P., Cicuttini, F., Largo, R., & Herrero‐Beaumont, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-06581-6 · Cited by 44 · see citing works
Lee, E. J., Ahmad, S. S., Lim, J. H., Ahmad, K., Shaikh, S., Lee, Y., Park, S. J., Jin, J., Lee, Y., & Choi, I. (2021) · Cells · doi:10.3390/cells10082083 · Cited by 44 · see citing works
Endurance training prevents TWEAK but not myostatin-mediated cardiac remodelling in cancer cachexia
Padrão, A. I., Moreira‐Gonçalves, D., Oliveira, P. A., Teixeira, C., Faustino‐Rocha, A. I., Helguero, L. A., Vitorino, R. M. P., Santos, L. L., Amado, F. M. L., Duarte, J. A., et al. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.12.026 · Cited by 43 · see citing works
Graça, F. A., Rai, M., Hunt, L. C., Stephan, A., Wang, Y., Gordon, B., Wang, R., Quarato, G., Xu, B., Fan, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30120-1 · Cited by 41 · see citing works
Establishment and phenotypic analysis of an Mstn knockout rat
Gu, H., Cao, Y., Qiu, B., Zhou, Z., Deng, R., Chen, Z., Li, R., Li, X., Wei, Q., Xia, X., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.030 · Cited by 39 · see citing works
Yang, S., Li, X., Liu, X., Ding, X., Xin, X., Jin, C., Zhang, S., Li, G., & Guo, H. (2018) · Oncotarget · doi:10.18632/oncotarget.24250 · Cited by 39 · see citing works
Yamakage, H., Tanaka, M., Inoue, T., Odori, S., Kusakabe, T., & Satoh‐Asahara, N. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13179 · Cited by 39 · see citing works
Xin, X., Yang, S., Li, X., Liu, X., Zhang, L.-L., Ding, X., Zhang, S., Li, G., & Guo, H. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.113237 · Cited by 37 · see citing works
Miao, C.-X., Lv, Y.-Y., Zhang, W., Chai, X., Feng, L.-X., Fang, Y., Liu, X., & Zhang, X.-W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00915 · Cited by 35 · see citing works
New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
Wang, Y., Wu, L.-L., Qi, X.-Y., Wang, Y.-Y., Liao, Z., Liu, J., & Xiao, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.013 · Cited by 35 · see citing works
Implication of diet and exercise on the management of age‐related sarcopenic obesity in Asians
Kim, Y. J., Moon, S., Yu, J. M., & Chung, H. S. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14442 · Cited by 33 · see citing works
The Use of Platelet-Rich and Platelet-Poor Plasma to Enhance Differentiation of Skeletal Myoblasts
Dragoo, J. L. (2016) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967116s00150 · Cited by 34 · see citing works
Tanaka, M., Masuda, S., Yamakage, H., Inoue, T., Ohue‐Kitano, R., Yokota, S., Kusakabe, T., Wada, H., Sanada, K., Ishii, K., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.041 · Cited by 32 · see citing works
Han, Y.-Q., Ming, S., Wu, H.-T., Zeng, L., Ba, G., Li, J., Lu, W., Han, J., Du, Q., Sun, M., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.009 · Cited by 32 · see citing works
The Role of Adipocytokines in Atherogenesis and Atheroprogression
Carbone, F., Mach, F., & Montecucco, F. (2015) · Current Drug Targets · doi:10.2174/1389450115666141109213439 · Cited by 31 · see citing works
Argilés, J. M. A. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.05.010 · Cited by 31 · see citing works
Gomes, C. P. C., de Gonzalo‐Calvo, D., Toro, R., Fernandes, T. M., Theisen, D., Wang, D., Devaux, Y., & on behalf of the Cardiolinc™ network (2018) · Clinical Science · doi:10.1042/cs20171463 · Cited by 30 · see citing works
Hepatocyte Growth Factor and Satellite Cell Activation
Anderson, J. E. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-27511-6_1 · Cited by 30 · see citing works
Leal, L. G., Lopes, M. A., Peres, S. B., & Júnior, M. L. B. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.570170 · Cited by 30 · see citing works
Cancer cachexia, a clinical challenge
Argilés, J. M. A., Busquets, S., & López-Soriano, F. J. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000517 · Cited by 28 · see citing works
Cui, Y., Yi, Q., Sun, W., Huang, D., Zhang, H., Duan, L., Shang, H., Wang, D., & Xiong, J. (2020) · BioFactors · doi:10.1002/biof.1675 · Cited by 30 · see citing works
Sarcopenia in chronic kidney disease: from bench to bedside
Kim, D. W., & Song, S. H. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.338 · Cited by 30 · see citing works
Hoffman, M. L., Peck, K. N., Wegrzyn, J., Reed, S. A., Zinn, S. A., & Govoni, K. E. (2016) · Journal of Animal Science · doi:10.2527/jas.2016-0570 · Cited by 28 · see citing works
Méloux, A., Rochette, L., Maza, M., Bichât, F., Tribouillard, L., Cottin, Y., Zeller, M., & Vergely, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010116 · Cited by 27 · see citing works
Nitric oxide treatment attenuates muscle atrophy during hind limb suspension in mice
Anderson, J. E., Zhu, A., & Mizuno, T. M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.021 · Cited by 25 · see citing works
Li, Y., Wang, Y., Willems, E., Willemsen, H., Franssens, L., Buyse, J., Decuypere, E., & Everaert, N. (2015) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12299 · Cited by 25 · see citing works
Ge, L., Dong, X., Gong, X., Kang, J., Zhang, Y., & Quan, F. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.043 · Cited by 25 · see citing works
Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety
Garutti, M., Sirico, M., Noto, C., Foffano, L., Hopkins, M., & Puglisi, F. (2025) · Current Obesity Reports · doi:10.1007/s13679-024-00604-w · Cited by 24 · see citing works
The role of extracellular vesicles in skeletal muscle wasting
Zhang, X., Zhao, Y., & Yan, W. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13364 · Cited by 24 · see citing works
Shabani, R., & Izaddoust, F. (2018) · Acta Gymnica · doi:10.5507/ag.2018.007 · Cited by 23 · see citing works
Raimondo, D. D., Miceli, G., Musiari, G., Tuttolomondo, M., & Pinto, A. V. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.30 · Cited by 23 · see citing works
Yang, H., Luo, L.-J., Chen, W.-J., Zhao, L., Tang, C., Qi, Y., & Zhang, J. (2014) · Endocrine · doi:10.1007/s12020-014-0233-y · Cited by 22 · see citing works
Single nucleotide polymorphisms in the upstream regulatory region alter the expression of myostatin
Hu, W., Chen, S., Zhang, R., & Lin, Y. (2013) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-013-9621-5 · Cited by 22 · see citing works
Treatment to Improve Nutrition and Functional Capacity Evaluation in Liver Transplant Candidates
Dasarathy, S. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0016-9 · Cited by 22 · see citing works
Epigenetics of cancer-associated muscle catabolism
Carr, R. M., Enriquez-Hesles, E., Olson, R. L., Jatoi, A., Doles, J. D., & Fernández-Zapico, M. E. (2017) · Epigenomics · doi:10.2217/epi-2017-0058 · Cited by 17 · see citing works
Kaur, M., & Misra, S. (2024) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2024-0065 · Cited by 16 · see citing works
Featured characteristics and pivotal roles of satellite cells in skeletal muscle regeneration
Song, T., & Sadayappan, S. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09553-7 · Cited by 16 · see citing works
Histone Deacetylases as Modulators of the Crosstalk Between Skeletal Muscle and Other Organs
Renzini, A., D’Onghia, M., Coletti, D., & Moresi, V. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.706003 · Cited by 15 · see citing works
Nutritional Considerations in Preventing Muscle Atrophy
Creţoiu, S. M., & Zugravu, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_23 · Cited by 16 · see citing works
Myostatin site‐directed mutation and simultaneous PPARγ site‐directed knockin in bovine genome
Ge, L., Kang, J., Dong, X., Luan, D., Su, G., Li, G., Zhang, Y., & Quan, F. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30017 · Cited by 15 · see citing works
“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
Hanna, D. J., Jamieson, S. T., Lee, C. S., Pluskota, C. A., Bressler, N., Benotti, P. N., Khurana, S., Rolston, D. D. K., & Still, C. D. (2021) · Obesity Science & Practice · doi:10.1002/osp4.509 · Cited by 13 · see citing works
Major determinants of circulating myostatin in polycystic ovary syndrome
Arpacı, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7080 · Cited by 14 · see citing works
Kramerova, I. A., Marinov, M., Owens, J. M., Lee, S., Becerra, D., & Spencer, M. J. (2020) · The Journal of Physiology · doi:10.1113/jp279943 · Cited by 14 · see citing works
Zhu, C., Liu, G., Gu, X., Yin, J., Xia, A., Han, M., Zhang, T., & Jiang, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.938526 · Cited by 14 · see citing works
Effect of eccentric contraction on satellite cell activation in human vastus lateralis muscle
Imaoka, Y., Kawai, M., Mori, F., & Miyata, H. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0385-4 · Cited by 14 · see citing works
Targeting Unique Epitopes on Highly Similar Proteins GDF-11 and GDF-8 with Modified DNA Aptamers
Ochsner, U. A., Green, L. S., Rice, T., Olivas, E., Janjić, N., & Katilius, E. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00760 · Cited by 13 · see citing works
Bonnet, M., Tournayre, J., & Cassar‐Malek, I. (2016) · Molecular BioSystems · doi:10.1039/c6mb00224b · Cited by 12 · see citing works
Kovanecz, I., Masouminia, M., Gelfand, R., Vernet, D. A., Rajfer, J., & González-Cadavid, N. F. (2017) · International Journal of Impotence Research · doi:10.1038/ijir.2017.22 · Cited by 12 · see citing works
Myostatin's marvels: From muscle regulator to diverse implications in health and disease
Sharma, S., & Patil, A. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4106 · Cited by 11 · see citing works
Tammam, A. A.-E., Rizg, W. Y., Boushra, A. F., Alhelf, M., Alissa, M., Soliman, G. F., Ouais, G. N., Hosny, K. M., Alkhalidi, H. M., & Elebiary, A. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1228525 · Cited by 10 · see citing works
Irisin and Myostatin Levels in Patients with Graves' Disease
Yalçın, M. M., Aktürk, M., Tohma, Y., Cerit, E. T., Altınova, A. E., Arslan, E., Yetkin, İ., & Törüner, F. B. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.11.002 · Cited by 10 · see citing works
Swan, J., Szabó, Z., Peters, J., Kummu, O., Kemppi, A., Rahtu‐Korpela, L., Konzack, A., Hakkola, J., Pasternack, A. H., Ritvos, O., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116683 · Cited by 9 · see citing works
Li, F., Shan, A. S., Hu, J., Zheng, Y.-L., Xu, L., & Chen, Z. H. (2013) · British Poultry Science · doi:10.1080/00071668.2013.853868 · Cited by 9 · see citing works
Turcotte, L. M., DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.236 · Cited by 8 · see citing works
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients
Mackels, L., Mariot, V., Buscemi, L., Servais, L., & Dumonceaux, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168763 · Cited by 8 · see citing works
Anderson, L. B., Ravara, B., Hameed, S., Latour, C. D., Latour, S. M., Graham, V. M., Hashmi, M. N., Cobb, B. A., Dethrow, N. M., Urazaev, A. K., et al. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab062 · Cited by 8 · see citing works
Serum Myostatin and Follistatin Levels in Patients With Dermatomyositis and Polymyositis
de Sordi, C. M., dos Reis-Neto, E. T., Keppeke, G. D., Shinjo, S. K., & Sato, E. I. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001806 · Cited by 8 · see citing works
Santos, H. O., Cerqueira, H. S. C., & Tinsley, G. M. (2022) · Metabolites · doi:10.3390/metabo12111146 · Cited by 8 · see citing works
Patalong-Wójcik, M., Golara, A., Zając, K., Sokołowska, A., Kozłowski, M., Tołoczko‐Grabarek, A., Krzyścin, M., Brodowska, A., Janiec, A., Myszka, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061574 · Cited by 7 · see citing works
Berstein, L. M., Евгеньевна, П. Т., & Vasilyev, D. A. (2017) · Obesity and metabolism · doi:10.14341/omet2017135-40 · Cited by 6 · see citing works
Chiang, J., Lin, L., Wu, C., Hwang, J., Yang, W., & Wu, Y. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.09.024 · Cited by 6 · see citing works
Khan, M. H., Fatima, M., Adnan, A. B., Jawaid, A., Hassan, S. M., Talal, M., Rahim, S., Mughal, Z. U. N., Patel, A. O., & Singh, A. K. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003584 · Cited by 6 · see citing works
Bonnet, M., Kaspric, N., Vonnahme, K. A., Viala, D., Chambon, C., & Picard, B. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124375 · Cited by 5 · see citing works
Editorial: The Fall of Mechanogrowth Factor?
Rotwein, P. S. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1411 · Cited by 5 · see citing works
Lima, W. P. (2017) · Revista Brasileira de Fisiologia do Exercício · doi:10.33233/rbfe.v16i2.972 · Cited by 3 · see citing works
Bonnet, M., Louveau, I., Cassar‐Malek, I., Lefaucheur, L., & Rescan, P. (2020) · INRAE Productions Animales · doi:10.20870/productions-animales.2015.28.2.3021 · Cited by 3 · see citing works
- Authors
- Argilés, J. M., Orpí, M., Busquets, S., & López-Soriano, F. J.
- Affiliations
- Institut de Biomedicina de la Universitat de Barcelona (ES)
- Universitat de Barcelona (ES)
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 17
- Issue
- 13-14
- Pages
- 702-709
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1975544443
- Cited by
- 125
- References
- 98
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 13 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 14 · 2017: 13 · 2016: 13 · 2015: 9 · 2014: 10 · 2013: 8
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
- Keywords
- myostatin, skeletal muscle mass, insulin sensitivity, wasting disease, muscle atrophy, heart, adipose tissue, therapeutic target
- MeSH terms
- Adipose Tissue, Animals, Cachexia, Exercise Therapy, Glucocorticoids, Humans, Insulin Resistance, Organ Size, Muscle, Skeletal, Wasting Syndrome, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review